CLBS-201

N/A

Report date: 2023/01/12 15:52:36

Base Information

Drug NameCLBS-201
Drug Alias NameCLBS-201
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsRenal Insufficiency, ChronicRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCaladrius Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesLisata Therapeutics IncCaladrius Biosciences Inc
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, ChronicRenal Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A